Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Neoadjuvant Chemoimmunotherapy NSCLC

Mariano Provencio

MD, PhD

🏢Hospital Universitario Puerta de Hierro, Madrid🌐Spain

Head of Medical Oncology

60
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Mariano Provencio led the NADIM and NADIM II trials demonstrating unprecedented pathologic complete response and overall survival with neoadjuvant nivolumab plus chemotherapy in resectable stage IIIA NSCLC. His investigator-initiated Spanish trials reshaped the perioperative paradigm worldwide. He continues to study biomarkers of pCR and long-term outcomes.

Share:

🧪Research Fields 研究领域

NADIM II trial
neoadjuvant chemo-immunotherapy
resectable stage IIIA NSCLC
pathologic response endpoint
Spanish Lung Cancer Group

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Mariano Provencio 的研究动态

Follow Mariano Provencio's research updates

留下邮箱,当我们发布与 Mariano Provencio(Hospital Universitario Puerta de Hierro, Madrid)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment